Permission form synopses to improve parents' understanding of research: a randomized trial.

ObjectiveWe hypothesized that, among parents of potential neonatal research subjects, an accompanying cover sheet added to the permission form (intervention) would increase understanding of the research, when compared to a standard form (control).Study designThis pilot study enrolled parents approached for one of two index studies: one randomized trial and one observational study. A one-page cover sheet described critical study information. Families were randomized 1:1 to receive the cover sheet or not. Objective and subjective understanding and satisfaction were measured.ResultsThirty-two parents completed all measures (17 control, 15 intervention). There were no differences in comprehension score (16.8±5.7 vs 16.3±3.5), subjective understanding (median 6 vs 6.5), or overall satisfaction with consent (median 7 vs 6.5) between control and intervention groups (all P>0.50).ConclusionA simplified permission form cover sheet had no effect on parents' understanding of studies for which their newborns were being recruited

Microwave enhanced chemical vapour infiltration of silicon carbide fibre preforms

An investigation into the fundamentals of the deposition of silicon carbide within porous silicon carbide fibre preforms using microwave-enhanced chemical vapour infiltration has been carried out. The study of the kinetics of deposition revealed an Arrhenius behaviour of the matrix growth rate against the temperature in the range 800-1000°C and a linear dependence on the pressure in the range 20 - 70 kPa. This is typical of a surface-reaction limited regime. The morphology of the SiC deposited changed with both temperature and pressure. Increases in both lead to a transition from a smooth, globular deposit morphology to something that was rougher and more angular; this corresponded to the transition from a nucleation to a growth regime. Stoichiometric SiC was predominantly found in the central region of the samples infiltrated at 1000°C, but the deposit became more silicon-rich (up to 2.6 at %) the farther from the initial deposit. Dielectric properties showed that ZMI Tyranno silicon carbide fibres readily absorbed microwave energy. In specific conditions of temperatures and pressures, 900-950°C and 50 kPa, an inside-out deposition pattern was observed indicating a temperature gradient across the preform. Deposition of silicon carbide and silicon caused the gradual flattening of the temperature gradient

Overview of Kyoto Fusioneering’s SCYLLA© (“Self-Cooled Yuryo Lithium-Lead Advanced”) Blanket for Commercial Fusion Reactors

This article outlines Kyoto Fusioneering’s (KF’s) initial engineering and development activities for its self-cooled lithium lead-type blanket: Self-Cooled Yuryo Lithium-Lead Advanced (SCYLLA©). We provide details on overall design, including an initial tritium breeding ratio (TBR) assessment via neutronics analysis, as well as the status of SCYLLA©-relevant R&D. This includes silicon carbide composite (SiCf/SiC) manufacturing techniques, tritium extraction, materials compatibility, and heat transfer, which are being explored via collaboration with Kyoto University. Results of previous work in relation to this R&D are presented. Permeability coefficients indicate a promising property of SiCf/SiC tritium hermeticity at high temperatures. Tritium extraction technology via vacuum sieve tray (VST) is shown to be demonstrated at engineering scale. A local TBR of up to 1.4 can be achieved with the SCYLLA© configuration. Fabrication methods for various SiCf/SiC components including the blanket module, heat exchanger, and flow path components are provided. A tritium compatible high-temperature SiCf/SiC heat exchanger is discussed. Commercial viability and reactor adaptability are considered as a theme throughout. Finally, KF’s plans to build a facility for demonstration reactor relevant testing of a SCYLLA© prototype in the mid-2020s, which will provide a significant step toward commercial fusion energy, are presented

Vasopressinergic modulation of stress responses in the central amygdala of the Roman high-avoidance and low-avoidance rat

The central nucleus of the amygdala (CEA) is selectively involved in the passive component of the behavioral (immobility) and the accompanying parasympathetic response during conditioned, stressful environmental challenges. Vasopressinergic mechanisms in the brain seem to play a role in these stress responses. The effects of the neuropeptides arginine-8-vasopressin (AVP) and oxytocin (OXT) on modulating CEA activity during conditioned stress of inescapable footshock were studied in male Roman high-avoidance (RHA/Verh) and low-avoidance (RLA/Verh) rats, psychogenetically selected on the basis of shuttle-box acquisition behavior. In RLA/Verh rats, the cardiac and behavioral responses to the conditioned emotional stressor were bradycardia and immobility, suggesting an important role for the CEA in these rats. The RHA/Verh rats, however, failed to show any change in heart rate or immobility in response to a conditioned stress situation. The low dose of AVP (20 pg) in the CEA of conscious RLA/Verh rats caused an enhancement of the stress-induced bradycardiac and immobility response. However, the high dose of AVP (2 ng) and OXT (200 pg) attenuated the bradycardiac and immobility responses in the RLA/Verh rats. Infusion of AVP and OXT in the RHA/Verh rats failed to induce any change in heart rate nr immobility. Binding studies revealed that the AVP receptor selectively binds AVP with high affinity. In contrast, the OXT receptor recognizes both AVP and OXT with a similar (but lower) affinity. This suggests that the behavioral and autonomic responses of the high dose of AVP may be caused by OXT receptor stimulation. In conclusion, on the basis of the present results one may hypothesize that CEA differences in AVP and OXT innervation and/or receptor densities may contribute to the differences in coping strategy found in these animals.

Frequency of apnea, bradycardia, and desaturations following first diphtheria-tetanus-pertussis-inactivated polio-Haemophilus influenzae type B immunization in hospitalized preterm infants

BACKGROUND: Adverse cardiorespiratory events including apnea, bradycardia, and desaturations have been described following administration of the first diphtheria-tetanus-pertussis-inactivated polio-Haemophilus influenzae type B (DTP-IPV-Hib) immunization to preterm infants. The effect of the recent substitution of acellular pertussis vaccine for whole cell pertussis vaccine on the frequency of these events requires further study. METHODS: Infants with gestational age of ≤ 32 weeks who received their first DTP-IPV-Hib immunization prior to discharge from two Edmonton Neonatal Intensive Care Units January 1, 1996 to November 30, 2000 were eligible for the study. Each immunized infant was matched by gestational age to one control infant. The number of episodes of apnea, bradycardia, and/or desaturations (ABD) and the treatment required for these episodes in the 72 hours prior to and 72 hours post-immunization (for the immunized cohort) or at the same post-natal age (for controls) was recorded. RESULTS: Thirty-four infants who received DTP-IPV-Hib with whole cell pertussis vaccine, 90 infants who received DTP-IPV-Hib with acellular pertussis vaccine, and 124 control infants were entered in the study. Fifty-six immunized infants (45.1%) and 36 control infants (29.0%) had a resurgence of or increased ABD in the 72 hours post-immunization in the immunized infants and at the same post-natal age in the controls with an adjusted odds ratio for immunized infants of 2.41 (95% CI 1.29,4.51) as compared to control infants. The incidence of an increase in adverse cardiorespiratory events post-immunization was the same in infants receiving whole cell or acellular pertussis vaccine (44.1% versus 45.6%). Eighteen immunized infants (14.5%) and 51 control infants (41.1%) had a reduction in ABD in the 72 hours post- immunization or at the equivalent postnatal age in controls for an odds ratio of 0.175 (95%CI 0.08, 0.39). The need for therapy of ABD in the immunized infants was not statistically different from the control infants. Lower weight at the time of immunization was a risk factor for a resurgence of or increased ABD post-immunization. Birth weight, gestational age, postnatal age or sex were not risk factors. CONCLUSION: There is an increase in adverse cardiorespiratory events following the first dose of DTP-IPV-Hib in preterm infants. Lower current weight was identified as a risk factor, with the risk being equivalent for whole cell versus acellular pertussis vaccine. Although most of these events are of limited clinical significance, cardiorespiratory monitoring of infants who are sufficiently preterm that they are receiving their first immunization prior to hospital discharge should be considered for 72 hours post-immunization

Rare non-Wilms' tumors in children

We report our institutional experience of the management of 2 cases of rare non-Wilms' tumors; a rhabdoid tumor in a 17-month old boy and a clear cell sarcoma in a 5-year old girl. The two patients were treated with ifosfamide/carboplatin/etoposide (ICE) alternating with vincristine/doxorubicin/cyclophosphamide (VDC) and cyclophosphamide/etoposide (CE) alternating with vincristine/doxorubicin/cyclophosphamide (VDC) and radiotherapy, respectively. Both patients showed full response with no significant adverse events. At 2-year follow up, they are disease and relapse free. Although contemporary treatment regimens are very promising, multicenter collaborative studies are needed in order to define a standard treatment for non-Wilms' tumors